Cost-Cutting Sanofi Resumes Fitusiran Studies, Starts COVID Vaccine Phase IIb This Month

2020 Revenues Led By Dupixent, Vaccines

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.